- WASHINGTON (Reuters) - The
U.S. government plans to vaccinate half a million health-care and emergency
workers against smallpox in case of a bioterror attack and is preparing
for mass vaccinations of the public, The New York Times reported on Sunday.
-
- The newspaper said the government's aggressive plans,
which it attributed to federal officials, are possible because the vaccine
has been produced rapidly and stockpiled since the Sept. 11 attacks on
New York and Washington.
-
- "Now we can act differently because we have more
vaccine," Dr. Donald A. Henderson, senior science adviser to Health
and Human Services Secretary Tommy G. Thompson.
-
- The U.S. plan to increase the number of workers vaccinated
to around 500,000 comes amid talk of war against Iraq, which some experts
suspect of hiding smallpox stocks.
-
- Henderson, who led the global smallpox eradication program,
told the Times that if there was a crisis, "we can make vaccine available
on request throughout the community."
-
- About 100 million doses of the smallpox vaccine are now
available and by late this year there will be enough for every American,
more than 280 million people, the Times reported.
-
- The government had initially planned to vaccinate only
a few thousand health workers against the highly contagious disease, which
was declared eradicated globally in 1980, eight years after the United
States stopped routine vaccinations.
-
- Jerome M. Hauer, acting assistant secretary for emergency
preparedness at Health and Human Services, said the agency hoped to send
blueprints for how to conduct mass vaccinations to cities and states in
the next week or two, the Times said.
-
- The newspaper reported hospital workers and smallpox
response teams would begin getting shots fairly soon.
-
- Smallpox used to killed one in three people who were
infected but not vaccinated, and most people today are considered vulnerable
because immunity is believed to diminish with time, the newspaper said.
-
-
- Copyright © 2002 Reuters Limited. All rights reserved.
Republication or redistribution of Reuters content is expressly prohibited
without the prior written consent of Reuters. Reuters shall not be liable
for any errors or delays in the content, or for any actions taken in reliance
thereon.
|
